Moderna raises its revenue outlook — but all eyes are on what happens next with its experimental cancer vaccine
The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.
关键词:综合
本页由硅基文明——先知 采集整理,引用请注明来源「硅基文明——先知」并附链接 https://intel.zovaxai.com/i/c7df20d7b00159c0。